H&F Corporate Investors VIII sold 1,500,000 shares (1.50M) for $73,001,250.01 at $48.67 on 2025-11-12, reducing stake 68.9%.
H&F Corporate Investors VIII, a 10% owner of Claritev, executed 6 separate sales totaling 1,500,000 shares (1.50M shares) for $73,001,250.01 ($73.0M) at $48.67, reducing its holdings by 68.9% from 2,177,590 shares to 677,590 shares. This substantial reduction occurs against a backdrop of material financial stress: the company generated $245,959,000.00 in latest-quarter revenue while posting a net loss of $-69,753,000.00 ($-69.8M), with annual revenue declining 3.2% and negative full-year net income. The transaction price of $48.67 stands $5.41 above the current price of $43.26, and the stock has declined 40.4% from its 52-week high of $72.58, further highlighting the deteriorating valuation environment since the sale. The scale and timing of this exit—liquidating nearly 70% of a substantial institutional stake—warrant investor attention to whether additional insider or institutional selling may follow.